Schechter Investment Advisors LLC lessened its holdings in shares of U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) by 34.9% in the first quarter, according to its most recent filing with the SEC. The firm owned 13,358 shares of the company's stock after selling 7,168 shares during the quarter. Schechter Investment Advisors LLC owned about 0.09% of U.S. Physical Therapy worth $967,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also modified their holdings of the company. HighTower Advisors LLC raised its stake in shares of U.S. Physical Therapy by 2.5% in the 4th quarter. HighTower Advisors LLC now owns 4,833 shares of the company's stock worth $429,000 after buying an additional 119 shares in the last quarter. Portside Wealth Group LLC raised its holdings in shares of U.S. Physical Therapy by 3.9% in the 1st quarter. Portside Wealth Group LLC now owns 4,108 shares of the company's stock worth $297,000 after purchasing an additional 154 shares in the last quarter. Precision Wealth Strategies LLC increased its holdings in shares of U.S. Physical Therapy by 6.6% in the first quarter. Precision Wealth Strategies LLC now owns 3,054 shares of the company's stock valued at $221,000 after buying an additional 189 shares in the last quarter. Aquatic Capital Management LLC lifted its holdings in shares of U.S. Physical Therapy by 18.0% during the fourth quarter. Aquatic Capital Management LLC now owns 1,298 shares of the company's stock valued at $115,000 after purchasing an additional 198 shares during the last quarter. Finally, Bessemer Group Inc. boosted its position in shares of U.S. Physical Therapy by 4.4% in the 1st quarter. Bessemer Group Inc. now owns 4,929 shares of the company's stock valued at $357,000 after purchasing an additional 208 shares during the period.
Wall Street Analyst Weigh In
Several analysts have issued reports on USPH shares. JMP Securities reissued a "market outperform" rating and set a $113.00 target price on shares of U.S. Physical Therapy in a research note on Tuesday, April 22nd. Barrington Research reissued an "outperform" rating and set a $98.00 target price on shares of U.S. Physical Therapy in a research note on Tuesday, July 1st. Finally, Wall Street Zen raised U.S. Physical Therapy from a "sell" rating to a "hold" rating in a research report on Thursday, May 8th. Two investment analysts have rated the stock with a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus target price of $109.00.
Get Our Latest Report on USPH
U.S. Physical Therapy Price Performance
Shares of USPH traded down $0.70 on Friday, hitting $74.26. The company's stock had a trading volume of 68,035 shares, compared to its average volume of 124,703. The company has a 50 day moving average price of $76.83 and a 200 day moving average price of $78.63. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.17 and a quick ratio of 1.17. The company has a market capitalization of $1.13 billion, a PE ratio of 34.06, a PEG ratio of 3.58 and a beta of 1.44. U.S. Physical Therapy, Inc. has a fifty-two week low of $62.77 and a fifty-two week high of $101.20.
U.S. Physical Therapy (NYSE:USPH - Get Free Report) last issued its earnings results on Wednesday, May 7th. The company reported $0.48 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.46 by $0.02. The company had revenue of $183.79 million for the quarter, compared to analyst estimates of $176.78 million. U.S. Physical Therapy had a net margin of 4.57% and a return on equity of 7.89%. The company's revenue for the quarter was up 18.0% on a year-over-year basis. During the same quarter last year, the firm earned $0.51 EPS. On average, research analysts anticipate that U.S. Physical Therapy, Inc. will post 2.67 earnings per share for the current fiscal year.
U.S. Physical Therapy Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Friday, June 13th. Stockholders of record on Friday, May 23rd were issued a $0.45 dividend. The ex-dividend date of this dividend was Friday, May 23rd. This represents a $1.80 dividend on an annualized basis and a dividend yield of 2.42%. U.S. Physical Therapy's dividend payout ratio (DPR) is presently 82.57%.
Insider Activity at U.S. Physical Therapy
In related news, Director Nancy Ham sold 400 shares of U.S. Physical Therapy stock in a transaction dated Thursday, June 12th. The stock was sold at an average price of $78.01, for a total value of $31,204.00. Following the sale, the director owned 2,594 shares of the company's stock, valued at approximately $202,357.94. The trade was a 13.36% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 2.00% of the stock is currently owned by corporate insiders.
U.S. Physical Therapy Profile
(
Free Report)
U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.
See Also

Before you consider U.S. Physical Therapy, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and U.S. Physical Therapy wasn't on the list.
While U.S. Physical Therapy currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.